GLI2 and melanoma: Additionally, the investigators observed that targeting the Hh transcription factors GLI1 and GLI2 restored the sensitivity of human melanoma cells resistant to vemurafenib and even inhibited acquired chemotherapy resistance in melanoma patients (74).